BIODESIX, INC. (BDSX) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $2.16M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value $906.00K; Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $2.16M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $2.16M |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | $906.00K | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Reported amount: $906.00K |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 86.18M USD | Liabilities |
| Borrowing debt | (m) | |
| Amounts owed to suppliers | 2.16M USD | Accounts Payable, Current |
| Total deferred revenue | (m) | Contract with Customer, Liability, Current · Contract with Customer, Liability, Noncurrent |
| Deferred revenue due within one year | 205.00K USD | Contract with Customer, Liability, Current |
| Deferred revenue due after one year | (m) | Contract with Customer, Liability, Noncurrent · Contract with Customer, Liability, Current |
| Reported other obligations due within one year | 906.00K USD | Other Liabilities, Current |
| Reported other noncurrent obligations | 704.00K USD | Other Liabilities, Noncurrent |
| Deferred revenue included in other noncurrent obligations | (m) | Contract with Customer, Liability, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- $906.00K
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $24.98M |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $2.16M | (m) | $906.00K | (m) | $86.18M | (m) | $205.00K | (m) | $704.00K | (m) |
| 2026-03-31 | (m) | $3.65M | (m) | $927.00K | (m) | $85.50M | (m) | $223.00K | (m) | $860.00K | (m) |
| 2025-12-31 | (m) | $3.08M | (m) | $992.00K | (m) | $89.94M | (m) | $961.00K | (m) | $1.02M | (m) |
| 2025-09-30 | (m) | $3.62M | (m) | $637.00K | (m) | $90.44M | (m) | $2.77M | (m) | $769.00K | (m) |
| 2025-06-30 | (m) | $2.97M | (m) | $638.00K | (m) | $86.60M | (m) | $617.00K | (m) | $549.00K | (m) |
| 2025-03-31 | (m) | $2.92M | (m) | $1.09M | (m) | $75.18M | (m) | $788.00K | (m) | $692.00K | (m) |
| 2024-12-31 | (m) | $2.19M | (m) | $641.00K | (m) | $76.37M | (m) | $678.00K | (m) | $815.00K | (m) |
| 2024-09-30 | (m) | $2.54M | (m) | $544.00K | (m) | $74.89M | (m) | $676.00K | (m) | $620.00K | (m) |
| 2024-06-30 | (m) | $2.22M | (m) | $386.00K | (m) | $79.58M | (m) | $447.00K | (m) | $744.00K | (m) |
| 2024-03-31 | (m) | $3.21M | (m) | $294.00K | (m) | $92.70M | (m) | $313.00K | (m) | $615.00K | (m) |
| 2023-12-31 | (m) | $2.93M | (m) | $293.00K | (m) | $94.52M | (m) | $324.00K | (m) | $712.00K | (m) |
| 2023-09-30 | (m) | $2.90M | (m) | $1.67M | (m) | $88.23M | (m) | $659.00K | (m) | $815.00K | (m) |
| 2023-06-30 | (m) | $3.50M | (m) | $285.00K | (m) | $84.62M | (m) | $1.07M | (m) | $896.00K | (m) |
| 2023-03-31 | (m) | $1.56M | (m) | $144.00K | (m) | $76.24M | (m) | $1.13M | (m) | $648.00K | (m) |
| 2022-12-31 | (m) | $1.69M | $1.36M | $41.00K | $558.00K | $72.30M | (m) | $962.00K | $400.00K | $558.00K | $0.00 |
| 2022-09-30 | (m) | $2.10M | $2.44M | $1.95M | $60.00K | $66.10M | (m) | $1.64M | $800.00K | $60.00K | $0.00 |
| 2022-06-30 | (m) | $1.79M | $3.03M | $1.15M | $70.00K | $67.56M | (m) | $2.23M | $800.00K | $70.00K | $0.00 |
| 2022-03-31 | (m) | $2.12M | $3.30M | $37.00K | $615.00K | $53.87M | (m) | $2.50M | $800.00K | $615.00K | $0.00 |
| 2021-12-31 | (m) | $1.66M | (m) | (m) | (m) | $56.37M | (m) | $1.85M | (m) | $1.39M | (m) |
| 2021-09-30 | (m) | $1.60M | (m) | (m) | (m) | $73.96M | (m) | $1.76M | (m) | $1.48M | (m) |
| 2021-06-30 | (m) | $1.16M | (m) | (m) | (m) | $76.03M | (m) | $2.18M | (m) | $1.59M | (m) |
| 2021-03-31 | (m) | $3.75M | (m) | (m) | (m) | $79.05M | (m) | $2.41M | (m) | $1.69M | (m) |
| 2020-12-31 | (m) | $8.96M | (m) | (m) | (m) | $79.90M | (m) | $3.53M | (m) | $1.92M | (m) |
| 2020-09-30 | (m) | $3.48M | (m) | (m) | (m) | $107.76M | (m) | $5.67M | (m) | $392.00K | (m) |
| 2019-12-31 | (m) | $1.72M | (m) | (m) | (m) | $76.21M | (m) | $1.28M | (m) | $358.00K | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |